Lifshitz Law PLLC Announces Investigations of Innoviz Technologies Ltd. (NASDAQ: INVZ), Nextdoor Holdings, Inc. (NYSE: KIND), Lantronix, Inc. (NASDAQ: LTRX), and Anavex Life Sciences Corporation (NASDAQ: AVXL)

Thursday, 18 April 2024 09:14 PM

Topic: 

Class Action

NEW YORK, NY / ACCESSWIRE / April 18, 2024 / Lifshitz Law Firm, P.C.

Innoviz Technologies Ltd. (NASDAQ:INVZ)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Innoviz Technologies overstated the benefits that the Company was likely to derive from its purported contracts, partnerships, and/or collaborations with automotive companies; (ii) as a result, Innoviz Technologies was unlikely to achieve the level of profitability that the Company represented to investors; (iii) accordingly, Innoviz Technologies overstated its business and/or financial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are an INVZ investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Nextdoor Holdings, Inc. (NYSE:KIND)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) Nextdoor Holdings' financial results prior to the Merger had been temporarily inflated by the ephemeral effects of the COVID-19 pandemic, which had pulled forward demand for the Company's platform and cannibalized future advertising revenue growth; (ii) rather than being sustained, such growth trends had already begun reversing at the start of the Relevant Period; (iii) the Company's total addressable market was materially smaller than the 312 million households represented to investors; (iv) by the start of the Relevant Period, Nextdoor Holdings' most important market, the U.S. market, was already substantially saturated, impairing the Company's ability to monetize users and increase its ARPU or U.S. WAUs; (v) as a result of the foregoing, Nextdoor Holdings' revenue guidance for fiscal year 2022 had no reasonable basis in fact and the Company was tracking tens of millions of dollars below the revenue trajectory provided to investors.

If you are a KIND investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Lantronix, Inc. (NASDAQ:LTRX)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Ocugen's financial statements from May 8, 2020 to the present were materially misstated; (ii) Ocugen did not have adequate internal controls; and (iii) as a result, the Company's statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

If you are a LTRX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Anavex Life Sciences Corporation (NASDAQ:AVXL)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that Anavex misled investors by providing a materially flawed and inaccurate impression of Anavex's research program and of blarcamesine's actual likelihood of success in its Phase II/Phase III Rett syndrome trials.

If you are an AVXL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2024 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

CONTACT:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

SOURCE: Lifshitz Law Firm, P.C.